drugset / Trial / NCT00177671

Antidepressant Medication Plus Donepezil for Treating Late-life Depression

NCT00177671 ↗

RandomizedParallel-groupTriple-blindTreatment

Summary

This study will determine the effectiveness of combining escitalopram, venlafaxine, or duloxetine with donepezil, a medication used in Alzheimer's disease, in improving memory, concentration, attention, and problem solving abilities, and reducing the risk of depressive relapse in older individuals with depression.

Timeline

Start
2003-12
Primary completion
2009-09
Completion
2009-09

Outcome

Missed primary endpoint

registry Donepezil vs Placebo; p = .05; Hazard Ratio (HR) 3.97 (95% CI 1.00 to 4.41); Log Rank NCT00177671 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Donepezil Small molecule 5 mg —
Subject Donepezil Small molecule 10 mg —
Background Duloxetine Small molecule 120 mg —
Background Escitalopram Small molecule 10 mg —
Background Escitalopram Small molecule 20 mg —
Background Venlafaxine Small molecule 150 mg —
Background Venlafaxine Small molecule 300 mg —